Skip to main content
Embla Medical hf logo

Embla Medical hf — Investor Relations & Filings

Ticker · EMBLA ISIN · IS0000000040 LEI · 213800K2AVTAFWJ4DP64 CO Manufacturing
Open in API
Filings indexed 1,164 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country IS Iceland
Listing CO EMBLA

About Embla Medical hf

https://www.emblamedical.com/

Embla Medical hf is a global provider of non-invasive orthopedic technologies and mobility solutions. The company develops, manufactures, and sells a range of products with a primary focus on prosthetics, neuro orthotics, and bracing and supports. It serves specialized healthcare providers, such as orthopedic and prosthetic clinics, hospitals, and surgery centers, through its direct sales channels. The company's stated mission is to help people live a "Life Without Limitations" by improving their mobility.

Recent filings

Filing Released Lang Actions
Embla Medical hf: Transactions in relation to Share Buyback Program
Regulatory Filings
2026-05-04 English
Embla Medical hf: Transactions in relation to Share Buyback Program
Regulatory Filings
2026-05-04 Danish
Embla Medical hf: Interim Report Q1 2026
Earnings Release Classification · 1% confidence The document is Embla Medical’s Q1 2026 interim performance announcement, summarizing sales, EBITDA, net profit, free cash flow, outlook, and referencing a link to the full report. It is not the full PDF report itself (it provides a link), but rather the initial press release of quarterly results with key highlights. This matches the “Earnings Release” (ER) category. Q1 2026
2026-04-28 English
Embla Medical hf: Interim Report Q1 2026
Interim / Quarterly Report Classification · 1% confidence The document is the full Q1 2026 interim report from Embla Medical hf, containing CEO comments, detailed highlights, actual financial statements (income statement, balance sheet, cash flow), key ratios and segment analysis. It is not merely an announcement or presentation but a comprehensive interim/quarterly report for a fiscal period shorter than a full year. Hence it matches the definition of an Interim / Quarterly Report (Code: IR). Q1 2026
2026-04-28 English
Embla Medical hf: Transactions in relation to Share Buyback Program
Transaction in Own Shares Classification · 1% confidence The document is an announcement detailing Embla Medical’s acquisition of its own shares under a share buyback program, including transaction dates, share counts, prices, and program details. This aligns directly with the “Transaction in Own Shares” category.
2026-04-27 English
Embla Medical hf: Transactions in relation to Share Buyback Program
Transaction in Own Shares Classification · 1% confidence The document is a detailed specification of share repurchase transactions by Embla Medical A/S, listing trade dates, quantities, prices, and total values of company buyback activity. This matches the definition for a Transaction in Own Shares report (share repurchase specification).
2026-04-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.